Mckesson 

M$9,489.53
414
+M$0+0% Wednesday 15:08

統計

當日最高
9,489.53
當日最低
9,489.53
52週最高
11,470
52週最低
7,688.45
成交量
2,900
平均成交量
13
市值
1.05T
市盈率
27.65
股息收益率
0.59%
股息
55.98

即將到來

股息

0.59%股息收益率
10年增長
14.56%
5年增長率
9.52%
3年增長率
10.66%
1年增長率
21.53%

收益

29Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
5.87
6.54
7.21
7.88
預期每股收益
7.391025
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 MCK.MX 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Show more...
首席執行官
Mr. Brian S. Tyler Ph.D.
員工
58000
國家
United States
ISIN
US58155Q1031

上市公司